$DNLI 3 SEC Filings

Filed On	Filing
20 Apr 2026	Form 3: Chin Peter Scott, Chief Medical Officer Holds 170,612 shares of Common Stock
06 Nov 2025	Form 3: Van Hauwermeiren Timothy, Director No securities owned
05 Jun 2025	Form 3: Baker Bros. Advisors Lp, Director and 5 others Holds 326,302 shares of Common Stock
05 Jun 2025	Form 3: Baker Julian, Director No securities owned
07 Feb 2022	Form 3: Harris Erik, Director No securities owned
12 Jan 2021	Form 3: Thornberry Nancy, Director No securities owned
28 Sep 2020	Form 3: Biogen Inc., 10% owner and 1 other Holds 13,310,243 shares of Common Stock
08 Nov 2018	Form 3: Cook Jennifer E., Director Holds 0 shares of No securities are beneficially owned.
20 Mar 2018	Form 3: Klein Peter S, Director Holds 0 shares of No securities are beneficially owned.
22 Dec 2017	Form 3: Fmr Llc, 10% owner Holds 2,999,521 shares of Common Stock
07 Dec 2017	Form 3: Flagship Ventures Fund V, L.p., 10% owner and 2 others Holds 312,500 shares of Common Stock
07 Dec 2017	Form 3: Arch Venture Fund VIII, L.p., 10% owner and 4 others Holds 312,500 shares of Common Stock
07 Dec 2017	Form 3: Tessier-Lavigne Marc, Director Holds 3,114,043 shares of Common Stock
07 Dec 2017	Form 3: Schenkein David P, Director Holds 75,000 shares of Common Stock
07 Dec 2017	Form 3: Sato Vicki L, Director Holds 75,000 shares of Common Stock
07 Dec 2017	Form 3: Nelsen Robert, Director Holds 312,500 shares of Common Stock
07 Dec 2017	Form 3: Bratton Douglas K, 10% owner and 7 others Holds 312,500 shares of Common Stock
07 Dec 2017	Form 3: Flatley Jay T, Director Holds 75,000 shares of Common Stock
07 Dec 2017	Form 3: Cole Douglas G., Director Holds 0 shares of No securities beneficially owned
07 Dec 2017	Form 3: Krognes Steve E., CFO and Treasurer Holds 500,000 shares of Common Stock

Comments